🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/01/1997 | 39,96 | 39,96 | 39,60 | 39,72 | -0,89% | 0,90% | 4.064.982 |
| 14/01/1997 | 39,78 | 40,37 | 39,72 | 40,08 | +1,20% | 1,65% | 5.602.608 |
| 13/01/1997 | 39,84 | 39,84 | 39,18 | 39,60 | -0,30% | 1,65% | 3.834.632 |
| 10/01/1997 | 39,00 | 39,72 | 38,82 | 39,72 | +0,76% | 2,29% | 4.122.413 |
| 09/01/1997 | 39,60 | 39,84 | 39,36 | 39,42 | +0,76% | 1,20% | 4.781.395 |
| 08/01/1997 | 39,72 | 39,90 | 39,00 | 39,12 | -1,20% | 2,25% | 4.884.728 |
| 07/01/1997 | 39,36 | 39,66 | 38,70 | 39,60 | +0,15% | 2,42% | 5.039.832 |
| 06/01/1997 | 39,42 | 40,08 | 39,18 | 39,54 | +0,30% | 2,27% | 7.512.693 |
| 03/01/1997 | 38,41 | 39,42 | 38,23 | 39,42 | +3,44% | 3,11% | 4.621.470 |
| 02/01/1997 | 37,99 | 38,11 | 37,21 | 38,11 | +0,31% | 2,35% | 5.675.758 |
| 31/12/1996 | 38,70 | 39,12 | 37,81 | 37,99 | -1,85% | 3,39% | 4.562.573 |
| 30/12/1996 | 38,88 | 39,18 | 38,47 | 38,70 | -0,61% | 1,84% | 4.517.090 |
| 27/12/1996 | 39,12 | 39,18 | 38,88 | 38,94 | -0,15% | 0,76% | 2.171.456 |
| 26/12/1996 | 39,72 | 39,84 | 38,82 | 39,00 | -1,80% | 2,55% | 3.622.517 |
| 24/12/1996 | 39,96 | 40,02 | 39,60 | 39,72 | +0,30% | 1,04% | 1.652.906 |
| 23/12/1996 | 39,42 | 39,72 | 39,24 | 39,60 | +0,45% | 1,21% | 3.295.122 |
| 20/12/1996 | 39,60 | 39,66 | 39,18 | 39,42 | +1,69% | 1,20% | 12.259.923 |
| 19/12/1996 | 37,69 | 38,82 | 37,57 | 38,76 | +5,69% | 3,32% | 7.936.923 |
| 18/12/1996 | 36,98 | 37,33 | 36,68 | 36,68 | +0,82% | 1,77% | 5.952.430 |
| 17/12/1996 | 36,02 | 36,74 | 35,90 | 36,38 | +0,49% | 2,32% | 5.454.630 |
| 16/12/1996 | 37,03 | 37,33 | 36,08 | 36,20 | -1,78% | 3,38% | 3.948.654 |
| 13/12/1996 | 36,26 | 37,39 | 36,26 | 36,86 | +1,31% | 3,13% | 6.771.757 |
| 12/12/1996 | 37,93 | 37,99 | 36,38 | 36,38 | -3,63% | 4,25% | 4.645.574 |
| 11/12/1996 | 37,57 | 37,87 | 37,27 | 37,75 | -0,63% | 1,59% | 3.906.944 |
| 10/12/1996 | 38,41 | 38,41 | 37,93 | 37,99 | -0,93% | 1,24% | 2.546.640 |
| 09/12/1996 | 37,45 | 38,35 | 37,45 | 38,35 | +2,88% | 2,39% | 3.933.354 |
| 06/12/1996 | 36,44 | 37,81 | 35,96 | 37,27 | -1,42% | 5,07% | 7.944.050 |
| 05/12/1996 | 37,93 | 38,53 | 37,51 | 37,81 | -1,86% | 2,67% | 4.741.990 |
| 04/12/1996 | 38,47 | 38,53 | 37,81 | 38,53 | -0,31% | 1,86% | 7.097.056 |
| 03/12/1996 | 39,12 | 39,66 | 38,53 | 38,65 | -1,52% | 2,90% | 4.454.000 |